Empowering MSMEs with News & Insights

New Pharmacopoeia edition to improve medicine standard

Updated: Nov 05, 2013 11:30:40am
image
New Delhi, Nov 5 (KNN) In order to improve the quality of medicines in India, 7th edition of Indian Pharmacopoeia 2014 – a book of Drug Standards has been launched.

The standards given in the book, launched by Union Health and Family Welfare Minister, Ghulam Nabi Azad here are authoritative, legally enforceable and intended to help in the inspection and licensing of manufacturing units and distribution of drugs and pharmaceuticals, according to an official statement.


The seventh edition of the Indian Pharmacopoeia (IP 2014) has been published by the Indian Pharmacopoeia Commission (IPC) in fulfilment of the requirements of the Drugs and Cosmetics Act, 1940. It prescribes the standards for drugs produced and/or marketed in India and thus contributes in the control and assurance of the quality of the medicines.


The Indian Pharmacopoeia 2014 comes in four volumes and its scope has been extended to include products of biotechnology, indigenous herbs and herbal products, veterinary vaccines and additional antiretroviral drugs and formulations, inclusive of commonly used fixed-dose combinations. Standards for new drugs and drugs used under National Health Programmes are added and the drugs as well as their formulations not in use now days are omitted from this edition.


The IP 2014 incorporates 2548 monographs of drugs out of which 577 are new monographs consisting of APIs, excipients, dosage forms, antibiotic monographs, insulin products and herbal products etc. 19 New Radiopharmaceutical Monographs and 1 General chapter is first time being included in this edition. It is hoped that this edition would play a significant role in improving the quality of medicines which in turn promote public health and accelerate the growth and development of Pharma Sector.


 The minister hoped that the Indian Pharmacopoeia 2014 will be able to fulfil the mission of the Indian Pharmacopoeia Commission to promote public health, both in India and other countries using drugs manufactured in India. (KNN/SD)

COMMENTS

    Be first to give your comments.

LEAVE A REPLY

Required fields are marked *